Boolean network-based analysis of the apoptosis network: irreversible apoptosis and stable surviving.
暂无分享,去创建一个
[1] J C Reed,et al. IAP family proteins--suppressors of apoptosis. , 1999, Genes & development.
[2] B. Gao,et al. Synergistic activation of JNK/SAPK induced by TNF-alpha and IFN-gamma: apoptosis of pancreatic beta-cells via the p53 and ROS pathway. , 2005, Cellular signalling.
[3] S. Shen,et al. Mitochondrial-dependent, reactive oxygen species-independent apoptosis by myricetin: roles of protein kinase C, cytochrome c, and caspase cascade. , 2005, Biochemical pharmacology.
[4] N. Sun,et al. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer. , 2006, The Annals of thoracic surgery.
[5] F. Allgöwer,et al. Bistability Analyses of a Caspase Activation Model for Receptor-induced Apoptosis* , 2004, Journal of Biological Chemistry.
[6] A. Thorburn,et al. An apoptosis signaling pathway induced by the death domain of FADD selectively kills normal but not cancerous prostate epithelial cells , 2001, Cell Death and Differentiation.
[7] Jian Yu,et al. The transcriptional targets of p53 in apoptosis control. , 2005, Biochemical and biophysical research communications.
[8] T. Chittenden,et al. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[9] Jochen H M Prehn,et al. Systems analysis of effector caspase activation and its control by X‐linked inhibitor of apoptosis protein , 2006, The EMBO journal.
[10] W. Fiers,et al. A20 inhibits NF-kappaB activation independently of binding to 14-3-3 proteins. , 1997, Biochemical and biophysical research communications.
[11] P. Krammer,et al. Molecular Mechanisms of Death‐Receptor‐Mediated Apoptosis , 2001, Chembiochem : a European journal of chemical biology.
[12] C. Lovly,et al. The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[13] T. Mak,et al. Signaling for survival and apoptosis in the immune system , 2002, Arthritis research.
[14] K. Hirokawa,et al. Expression of IAP family proteins in esophageal cancer. , 2004, Experimental and molecular pathology.
[15] A. Philchenkov. Caspases: potential targets for regulating cell death , 2004, Journal of cellular and molecular medicine.
[16] D. Lauffenburger,et al. Quantitative analysis of pathways controlling extrinsic apoptosis in single cells. , 2008, Molecular cell.
[17] S. Lowe,et al. Intrinsic tumour suppression , 2004, Nature.
[18] B. Gao,et al. Synergistic activation of JNK/SAPK induced by TNF-α and IFN-γ: Apoptosis of pancreatic β-cells via the p53 and ROS pathway , 2005 .
[19] C. Ferran,et al. A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. , 1998, Blood.
[20] Michael Berger,et al. Apoptosis - the p53 network , 2003, Journal of Cell Science.
[21] S. Bao,et al. The activation of Akt/PKB signaling pathway and cell survival , 2005, Journal of cellular and molecular medicine.
[22] P. Brandt-Rauf,et al. Selective induction of apoptosis through the FADD/caspase‐8 pathway by a p53 c‐terminal peptide in human pre‐malignant and malignant cells , 2005, International journal of cancer.
[23] Q. Ouyang,et al. The yeast cell-cycle network is robustly designed. , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[24] Nils Blüthgen,et al. Mathematical Modeling Identifies Inhibitors of Apoptosis as Mediators of Positive Feedback and Bistability , 2006, PLoS Comput. Biol..
[25] A. Goldberger,et al. Emergence of complex dynamics in a simple model of signaling networks. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[26] Olaf Wolkenhauer,et al. Mathematical modelling in the post-genome era: understanding genome expression and regulation--a system theoretic approach. , 2002, Bio Systems.
[27] Casein kinase Iepsilon down-regulates phospho-Akt via PTEN, following genotoxic stress-induced apoptosis in hematopoietic cells. , 2006, Life sciences.
[28] C. Lovly,et al. The role of NF-κB-1 and NF-κB-2-mediated resistance to apoptosis in lymphomas , 2006 .
[29] Guy S. Salvesen,et al. X-linked IAP is a direct inhibitor of cell-death proteases , 1997, Nature.
[30] E. Wang,et al. Signaling pathway for apoptosis: A racetrack for life or death , 1999, Journal of cellular biochemistry.
[31] Christoph H Emmerich,et al. TRAIL signalling: decisions between life and death. , 2007, The international journal of biochemistry & cell biology.
[32] J. Gillette,et al. Role of PTEN and Akt in the regulation of growth and apoptosis in human osteoblastic cells , 2003, Journal of cellular biochemistry.
[33] R. Silber,et al. Expression of inhibitors of apoptosis (IAP) proteins in non-small cell human lung cancer , 2002, Journal of Cancer Research and Clinical Oncology.
[34] J. Tschopp,et al. Life and death decisions: secondary complexes and lipid rafts in TNF receptor family signal transduction. , 2004, Immunity.
[35] S. Korsmeyer,et al. BCL-2 family members and the mitochondria in apoptosis. , 1999, Genes & development.
[36] P. Leder,et al. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. , 1998, Immunity.
[37] R. K Srivastava,et al. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells. , 2002, Cancer research.
[38] Stefan Grimm,et al. The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal , 1998 .
[39] G. Giaccone,et al. Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patients. , 2001, Annals of oncology : official journal of the European Society for Medical Oncology.
[40] K. Hirokawa,et al. Expression of IAP family proteins in colon cancers from patients with different age groups , 2004, Cancer Immunology, Immunotherapy.
[41] G B Ermentrout,et al. Bistability in apoptosis: roles of bax, bcl-2, and mitochondrial permeability transition pores. , 2006, Biophysical journal.
[42] M. Lutter,et al. Biochemical pathways of caspase activation during apoptosis. , 1999, Annual review of cell and developmental biology.
[43] W. Fiers,et al. A20 Inhibits NF-κB Activation Independently of Binding to 14-3-3 Proteins , 1997 .
[44] J. Ferrell. Self-perpetuating states in signal transduction: positive feedback, double-negative feedback and bistability. , 2002, Current opinion in cell biology.
[45] M. Fraser,et al. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner. , 2006, Gynecologic oncology.
[46] Kwang-Hyun Cho,et al. Coupled positive feedbacks provoke slow induction plus fast switching in apoptosis , 2007, FEBS letters.
[47] E. Henson,et al. Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy. , 2006, Cellular signalling.
[48] S. Kauffman. Metabolic stability and epigenesis in randomly constructed genetic nets. , 1969, Journal of theoretical biology.
[49] J. Stelling. Mathematical models in microbial systems biology. , 2004, Current opinion in microbiology.
[50] R. Korneluk,et al. Thymocyte-targeted overexpression of xiap transgene disrupts T lymphoid apoptosis and maturation , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[51] R. Eils,et al. Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis , 2004, The Journal of cell biology.
[52] Masashi Narita,et al. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC , 1999, Nature.
[53] Y. Soini,et al. Expression of caspases‐3, ‐6 and ‐8 and their relation to apoptosis in non‐small cell lung carcinoma , 2001, International journal of cancer.
[54] S. Huang,et al. Shape-dependent control of cell growth, differentiation, and apoptosis: switching between attractors in cell regulatory networks. , 2000, Experimental cell research.
[55] D. Lauffenburger,et al. A Systems Model of Signaling Identifies a Molecular Basis Set for Cytokine-Induced Apoptosis , 2005, Science.
[56] M. Kelliher,et al. The Death Domain Kinase RIP Is Essential for TRAIL (Apo2L)-Induced Activation of IκB Kinase and c-Jun N-Terminal Kinase , 2000, Molecular and Cellular Biology.
[57] D. Goeddel,et al. The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[58] J. Ashwell,et al. TNF‐α induced c‐IAP1/TRAF2 complex translocation to a Ubc6‐containing compartment and TRAF2 ubiquitination , 2005, The EMBO journal.
[59] James E. Ferrell,et al. Bistability in cell signaling: How to make continuous processes discontinuous, and reversible processes irreversible. , 2001, Chaos.